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Summary 
During persistent infection of scid mice with Borrelia turicatae,  an agent of relapsing fever and 
neuroborreliosis, there was variation in the surface proteins the bacteria expressed and in disease 
manifestations over time. Two serotypes, A and B, were isolated from the mice, doned by limiting 
dilution, and further characterized.  The only discernible  difference between the two variants 
was in the size of the major surface protein they expressed:  serotype A  had a variable major 
protein (Vmp) of 23,000,  and serotype B had a Vmp of 20,000.  When other scid mice were 
inoculated with clonal populations of A and B, the infections were similar with respect to onset 
and degree of spirochetemia, involvement of the eye and heart, and occurrence of a peripheral 
vestibular disorder. However, there were differences between the serotypes in other respects: (a) 
serotype B but not A  caused reddened and significantly enlarged joints, markedly impaired 
performance on a walking bar,  and severe arthritis by histologic examination; (b) serotype A 
but not B invaded the central nervous system during early infection; and (c) serotype A penetrated 
monolayers of human umbilical vein endothdial cells more readily than did serotype B. The 
combination of arthritis, myocarditis, and neurologic disease resembled human Lyme borreliosis. 
The findings indicate that differences in disease expression are determined by variable  surface 
proteins of the bacterium and that scid mouse infections with R  turicatae provide a model for 
the study of the pathogenesis of Lyme borreliosis  and other persistent spirochetal  diseases. 
D 
uring Lyme borreliosis  there is sequential involvement 
over weeks to years of different organs, including heart, 
joints, central and peripheral nervous systems, and eyes (1). 
Although viable bacteria dearly initiate disease, the host's 
immune response to the agent determines in part the severity 
of that disease (2-4). To further delineate the relative contri- 
butions of parasite  and host in this pathogenesis equation 
an animal model would be hdpful. Infections with Borrelia 
burgdorferi,  the agent of Lyme borrdiosis, have been estab- 
lished in laboratory animals, including mouse, rat, hamster, 
rabbit, and gerbil (5-9). In both immunocompetent and im- 
munocompromised  animals these infections have involved the 
joints and heart, but there has been little or no evidence of 
disease of the nervous system in these animal models. Infec- 
tion of the brain by/g burgdorferi is inconsistent and short- 
lived,  even in immunodeficient animals (5, 6,  10,  11). 
A closely related group of spirochetes in the genus Borrel/a 
cause relapsing fever (12). The two principal species that pro- 
duce disease in North America are R  herrnsii and/g turicatae 
(13). The infection of both humans and experimental animals 
is characterized by periodic illness of the host and antigenic 
variation of the etiologic spirochete in the blood (14). A fea- 
ture of relapsing fever that is less appreciated  now than in 
the past is the involvement of the nervous system in human 
infections (15, 16). Several  decades ago investigators first noted 
that certain strains ofrdapsing fever borrelias were neurotropic 
(17, 18). The specific phenomenon that these earlier investi- 
gators noted was the propensity of some but not all strains 
of borrelias to invade the nervous tissue and persist there for 
weeks to years (19, 20). Neurotropism was observed not only 
in laboratory animals but in the vector ticks as well (21). 
Relapsing fever borrelia strains have a large repertoire of pro- 
teins to display on their surface (22),  and therefore it was 
possible that the neurotropic potential within a strain was 
conferred by one or more of these variable proteins. 
The original goal of the study was to establish persistent 
infection by a Borrelia species of the brain of a laboratory an- 
imal. This aim was achieved, but as notable were the findings 
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were differences in disease expression with different variants. 
Most surprising was the similarity of the disease we observed 
in infected mice to systemic Lyme borreliosis of humans. 
Materiah  and Methods 
Strains and Culture Conditions.  R  turicatae was isolated  by in- 
jecting Swiss mice with tissues from Ornithodoros turicata collected 
in a cave near Ozona, TX (23). R hermsii  strain HS1 (35209; Amer- 
ican  Type Culture  Collection,  Rockville, MD)  and Spirochaeta 
aurantia strain M1 have been described previously (24, 25). Borrelias 
were cultured in BSK II medium with 12% rabbit serum (26), and 
& aurantia was grown in YT medium (25). When tissue samples 
were cultured, rifampin at 50 ~g/ml and phosphomycin at  100 
~g/ml were present in the medium. Intrastrain borrelia variants 
with different variable major proteins (Vmp's) 1 were designated by 
convention "serotypes" and, to distinguish the Vmp's from those 
ofR hermsii, they were also designated by letters instead of numbers 
(22). Serotypes were cloned by limiting dilution in BALB/c mice 
(Harhn Laboratories, Indianapolis, IN) irradiated with 650 tad from 
a ~TCs gamma source (24).  Plasma  samples  from infected mice 
were either frozen with 10% DMSO at  -80~  or used to start 
broth cultures, which at cell densities  of 10Vml were aliquoted 
and similarly frozen until use. Spirochetes were counted in a Petroff- 
Hanser chamber under phase contrast microscopy (24). 
Protein and Nucleic Acid Analysis.  Whole cells from harvested 
cultures were subjected to SDS-PAGE with 12.5 or 14% acrylamide 
(22). Surface-exposed proteins of intact borrelias were cleaved with 
proteinase K (Boehringer Manaheim Corp., Indianapolis,  IN) and 
examined by PAGE as descn'bed (27). Total DNA was obtained from 
the borrelias,  digested with restriction enzymes, and subjected to 
agarose  gd dectrophoresis as described  (28). 
Monolayer Penetration Assay.  Spirochetes in late-log phase cul- 
tures were harvested by centrifugation (5 min at 7,000 g) and after 
washing,  adjusted to 109 cells/m1 in M199 medium (Gibco Labora- 
tories, Grand Island, NY) containing 20% FCS. Human umbilical 
vein endothelial cells were isolated from freshly ddivered umbilical 
cords by the method ofJaffe et al. (29). The cells were maintained 
in an atmosphere of 5% CO2 in air at 370C in M199 medium, 
100/~g/ml of heparin, and 50 ng/ml of endothelial cell growth 
supplement (Gibco Laboratories).  Confirmation of endothelial cell 
character and penetration assays were conducted as previously de- 
scribed (30). Briefly, 2.5  x  104 endothelial cells were seeded onto 
3-~m pore size, 6.5-ram diameter sterile polycarbonate membrane 
culture plate inserts (Nucleopore, Pleasanton, CA). Chambers were 
placed in 24-wdl plates containing 1 re_l/well  M199 with FCS. After 
incubation for 48 h, the monolayers were confluent, and high trans- 
endothelial resistance  was confirmed; aliquots of 108 spirochetes 
in 0.2 ml medium were ~_dd~ to the upper portions of the chambers. 
At different times of incubation, aliquots from beneath the filter 
were removed, and spirochetes were directly counted as described 
above. The assay was performed three times. 
Mouse Infections.  4-6-wbold  female  BALB/c mice  (Harlan 
Laboratories) or male CB-17 scid mice (Charles River Laboratories, 
Wilmington, M_A) were inocuhted intraperitoneally or intracere- 
brally with borrelia suspensions  in 300 and 60/~1 of PBS, respec- 
tively. Control mice received PBS alone, sad mice were maintained 
in a germ-frec environment before and after infection. For evalua- 
t Abbreoiations used in this paper: CI, confidence interval; Vmp, variable 
major protein. 
tion of spirochetemia, tail vein blood was mixed with an equal 
volume of PBS and examined by phase contrast microscopy.  The 
mice  were  examined  daffy,  and  presence  of these  signs  were 
specifically noted: ruffled fur, eye discharge,  reddened joints, head 
tilt, spinning in the air when lifted off the ground by the tail, and 
walking in circles (31). Abnormal signs were confirmed by an ob- 
server who did not know whether the mouse was infected or not. 
The sizes of the tibiotarsal joints and metatarsal  regions at their 
greatest diameter were measured with a vernier caliper. Mouse sera 
were  examined  for  anti-borrelia  antibodies  by  indirect  im- 
munofluorescence as previously described (22). 
Beam  Walking Test.  The mice were trained on a  stationary 
horizontal beam 48 and 24 h before test trials (32). The Plexiglas 
beam measured 120 (length)  x  1.2 (thickness)  x  0.7 (width) cm, 
had phtforms at both ends, and was at a 50 cm height. Test trials 
consisted in three complete crossings of the beam. For every crossing 
two determinations were made: traversing time in seconds and the 
number of times one of the hind feet slipped  off the beam. 
Tissue and Fluid Collection.  Mice were killed  with methoxy- 
flurane. Sodium citrate was used as an anticoagulant for blood col- 
lection by heart puncture. Total body peffusion with 30 ml PBS 
was performed as described (33). After the skull was opened under 
sterile conditions, brain tissue was removed and rinsed twice with 
1 ml of PBS in sterile 2-ml microfuge tubes (Sarstedt Inc., Newton, 
NC). To the brain tissue  sample was added twice its volume of 
BSK II medium.  With plungers of sterile  1-ml plastic  syringes 
(Becton Dickinson & Co., Mountain View, CA) the brain tissue 
was homogenized in the tubes and then suspended  in medium by 
briefly vortexing. Blood and brain suspensions  were centrifuged 
for 5 s at 7,000 g. If red blood calls were observed microscopically 
in the brain suspension or as a layer in the brain pellet, the sample 
was discarded. Eyes and fibiotarsaljoints were removed, rinsed with 
sterile PBS, and then added en block to culture tubes (34). Samples 
from uninfected mice were processed as negative controls for cross 
contamination between mice during procedures.  All cultures were 
examined for a 3-wk period. 
HistopathologicalStudies.  Internal organs inclnding brain, heart, 
and testis and different  joints of mice were removed after total body 
perfusion with buffer. Tissues were immersion fixed in 10% neu- 
tral buffered formalin. The bones were decalcified in 5% nitric acid 
after fixation. Hematoxylin and eosin-stained slides were prepared 
by standard histologic methods. The slides were read by a veteri- 
nary pathologist (K. Crawley) without prior knowledge of which 
animals were infected and, if infected, with which serotype. The 
amount of inflammation in cardiac and synovial tissues was graded 
as none, mild, moderate, or severe. The criteria for grading arthritis 
were the following: mild, focal inflammation of synovial membrane 
with minimal exudation into joint space or periarticular tissues; 
moderate, coalescing areas of inflammation in the synovial mem- 
branes with moderate exudation into the joint space or periartic- 
ular tissues;  and severe, inflammation of synovial membrane in- 
volving the entire joint with marked exudation into the joint space 
and periarticular tissues. The criteria for grading carditis were the 
following: mild, multifocal but nonconfluent leukocytic accumu- 
lation in myocardial or pericardial tissues; moderate, multifocal leu- 
kocytic accumulations that were confluent in some areas; and se- 
vere, largely confluent or transmural areas of inflammation. 
Results 
Isolation of Serot),pes A  and R  The present study began 
as an attempt to find an animal model of spirochete infection 
in which persistent infection of the brain occurred. We had 
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system  of  mice (33). However, after a preliminary study showed 
that R  hermsii infections of the brain of BALB/c mice did 
not last beyond 2 wk, we considered other Borrel/a species. 
Previous reports had indicated that among the relapsing fever 
Borrel/a species, R  turicatae was often associated with neuro- 
logic disease in humans (16). The Ozona strain of this spe- 
des was implicated in an outbreak of relapsing fever, which 
was first thought to be Lyme disease on the basis of cranial 
neuritis (23). Using BALB/c mice we first documented the 
invasion of the brain by the Ozona strain ofR turicatae. Four 
mice were inoculated intraperitoneally with 103 borrelias on 
day 0. Borrelias were microscopically detectable in or cultiv- 
able from the blood in two mice examined on day 10 but 
not in mice examined on days 24 and 31.  In contrast,  the 
perfused brain contained cultivable R  turicatae on days 24 and 
31  as well as 10.  With the exception of ruffled fur when 
spirochetemic, the infected mice did not appear to be ill. 
Different results were obtained with two scid mice who 
were given the same inoculum and similarly examined for 
blood and brain infection at various times.  The mice had 
spirochetemia at all examinations and, in addition to ruffled 
fur, had a self-limited mucopurulent discharge from the eyes 
early in the infection. The PAGE  profiles  from  brain and plasma 
isolates obtained from one mouse examined on day 7 and from 
the other mouse examined on days 50 and 100 are shown 
in Fig. 1, 1~/. Isolates from the plasma and brain of  the mouse 
examined on day 7 were identical to one another but differed 
from isolates taken from the mouse examined on days 50 and 
100. The differences  between isolates were in major proteins 
with apparent Mr of 20,000-35,000 (35 K). Day 7 brain and 
plasma isolates had major proteins of 33, 22, and 21 K not 
present in the other isolates. Later isolates uniquely had ei- 
ther or both proteins of 23 and 20 K. Days 50 and 100 blood 
populations from the second mouse produced both proteins, 
albeit less of the 23 K protein by day 100 (Fig. 1). In con- 
trast, the brain isolate from day 100 detectable produced only 
the 23 K Vmp protein. 
Characterization of  Serotypes A  and R  This experiment in- 
dicated that even  in immunoddicient mice variation of  major 
proteins of a relapsing fever borrdia occurred over time. Fur- 
thermore, populations of borrelias in the brain and blood of 
the same animal differed, the implication  being that some 
isolates are more neurotropic than others. If this was the case, 
then one would expect in a prospective study that the variant 
expressing the 23K protein would more likely infect the brain 
than the variant population expressing predominantly the 20 
K protein.  For evaluation of this hypothesis donal popula- 
tions of the two variants were needed. These were obtained 
by cloning by limiting dilution in irradiated mice. First pas- 
sage cultures of  the clonal populations were characterized  with 
respect to profiles of their total proteins  and restriction en- 
zyme digests, growth rate, infectivity, and in vitro invasive- 
ness. The phenotypes that are described below for the two 
clones were stable after further passage in both broth medium 
and scid mice. 
Fig. 1, right, shows the total cellular proteins of the two 
Figure 1.  Coomasie blue-stained  proteins in whole cell lysates of iso- 
lates ofR turicatae. The migrations of  molecular weight standards (x 1,000) 
are shown on the left. (Left) 14% acrylamide gel of brain (b) and plasma 
(p) isolates  from days  7, 50, and 100 of  sc/d  mice inoculated with/~ turicatae. 
The p7 and b7 isolates were from one mouse and the p50, p100, and bl00 
isolates from a  second mouse.  The arrow  indicates a faint protein of 
23 K that is more prominent in the p50 and bl00 hnes. (Right)  12.5% 
acrylamide gel of cloned isolates from bl00 and pl00 populations,  now 
designated serotypes A and B, respectively. In the two rightmost lanes 
of this gel the cells had first been treated with proteinase K. The Vmp 
proteins of 23 and 20 K in A and B populations were cleaved by the pro- 
tease. Two other proteins  that were cleaved in situ by the protease and 
were the same in cultures from both populations  are indicated by asterisks. 
The upper band is BSA from  the medium. 
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clonal populations.  The variant expressing the 23 K protein 
was designated serotype A, and this variant-specific protein 
was called VmpA. The corresponding designations  for the 
other variant population were serotype B and VmpB. Previous 
studies with R  burgdo~ri and R  hermsii indicated that sero- 
typic specificity is largely determined by major proteins  of 
20-35 K that are surface  exposed (35, 36). When intact, viable 
cells were treated with proteinase K, VmpA and VmpB were 
cleaved from the cells (37), as shown in Fig.  1, and also in 
gels  with a higher concentration  of acrylamide. Two pro- 
teins common to serotypes A  and B were also affected by 
the in situ protease treatment: one of 69 K, which corre- 
sponds to the bovine  albumin in the medium,  and one of 
65 K (Fig.  1). The latter protein is probably homologous 
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B, hermsii that are likewise cleaved in situ by proteases (38, 
39). There was no detectable difference in the restriction frag- 
ment profiles ofBgllI, PstI, and HindlII digests of total DNA 
of the two serotypes (data not shown), an indication  that 
the two serotypes were substantially isogenic. 
The polymorphic character of Vmp proteins was demon- 
strated in two immunocompetent BALB/c mice inoculated 
with 104 cells of donal populations of serotype A or B. The 
tail vein blood was cultured at the time of the peak spiro- 
chetemia and relapse spirochetemia,  and the isolates were 
characterized by PAGE (data not shown). In the relapse popu- 
lation of the mouse inoculated with serotype A, VmpA was 
replaced by Vmp's of 37 and 21 K. In the mouse inoculated 
with serotype B the relapse population expressed a Vmp of 
22 K instead of VmpB. 
Serotypes A and B were examined with respect to growth 
rate in culture and infectivity of  mice. The mean growth rates 
at 34~  for three determinations (95% confidence intervals 
[95% CI]) for serotypes A and B were 6.9 (5.9-7.9)  h and 
7.1 (6.9-7.3) h, respectively. When groups of three irradi- 
ated BALB/c mice each were inoculated intraperitoneally with 
an estimated 103, 101, 10  ~ and 10-1 spirochetes of serotype 
A or B, the number of infected mice in each group, in order 
of descending inoculum size, were 3, 3, 2, and 0 for serotype 
A and 3, 3, 1, and 0 for serotype B. This indicated that either 
serotype can produce infection with as few as one or two 
cells, as $chuhardt found with another strain of/~ turicatae 
(40). When scid mice were inoculated with 103 cells of ei- 
ther serotype A or B, spirochetes were detectable by daily 
phase contrast microscopy of tail vein blood by day 4. These 
experiments indicated that serotypes A and B had similar ca- 
pacities to grow in culture and to establish infection in mice. 
In an initial  study of biological differences between the 
two serotypes, the ability of the spirochetes to pass through 
monolayers of human umbilical vein endothelial calls was as- 
sessed. The mean percentage  (95%  CI) of the number of 
borrelias added to the upper part of the chamber that were 
detected on the other side at 6 h was 10.0 (8.8-11.3) for sero- 
type A, 4.6 (4.1-5.0)  for serotype B and 0.7 (0.4-0.9) for 
the nonpathogenic spirochete $. aurantia. 
Differences in Disease in Serotype A- and B-inoculated Mice. 
The previous findings suggested that/g  turicatae serotypes 
A and B, while detectably identical in all respects except in 
the Vmp proteins  and ~  vitro invasiveness, might differ in 
the diseases they produced. To assess this scid mice were in- 
fected with the donal Populations of serotypes A or B. Mice 
numbered 1-29 were divided into groups  of 4,  12, and 13 
mice, which were injected intraperitoneally  with PBS, 103 
serotype A cells, or 103 serotype B cells in PBS, respectively, 
on day 0. From each of the infected groups four to five  mice 
were taken on days 4, 11, and 31, and their organs and tissues 
were sampled for culture. All mice were spirochetemic  through 
the 31 d of study. There was no difference between A- and 
B-inoculated  mice in the spirochete count in the blood at 
any point. 
Fig. 2 summarizes disease expression in the mice. By day 
8 the eight remaining mice inoculated with serotype A and 
the nine remaining mice inoculated with serotype B were 
listless and had ruffled fur. Mucopurulent discharge from the 
eyes beginning by day 8 and not lasting beyond day 13 was 
observed in mice infected with either serotype but more com- 
monly in those infected with B. The joints were involved 
next. Tibiotarsaljoint  and metatarsal region reddening  began 
on day 10,  11, or 12 in all serotype B-inoculated mice but 
not at all in control or serotype A-inoculated mice. The mean 
sizes of the right and left tibiotarsaljoints for control, A-inocu- 
lated, and B-inoculated mice for days 12-31 are shown in Fig. 
3 A. Measurements of the metatarsal regions of these animals 
for days 15-21 are given in Fig. 3 B. The  joints of  B-inoculated 
mice were significantly larger than those of either control 
or A-inoculated mice. The measurable  joint enlargement lasted 
a few days longer than joint reddening evident on eye exami- 
nation (Fig. 2). Joint involvement recurred on day 30 in two 
of five B-inoculated mice (Figs. 2 and 3). 
To confirm an association between  joint disorder and sero- 
type B a second group (II) of scid mice (nos. 30-39)  were 
inoculated with PBS (n  =  2), 103 serotype A cells (n =  4), 
or 103 serotype B cells (n =  4). Joints were measured daily; 
results for days 10-14 are given in Fig. 3 C. Reddened  joints 
on days 12-14 were again noted in B-inoculated mice but 
not in control or A-inoculated  mice. Tibiotarsal joints of 
B-inoculated mice on days 12-14 were significantly  larger than 
joints of control or A-inoculated mice. In group II as well 
as group I, the  joints of A-inoculated mice were slightly larger 
than those of  control mice. On day 14 the animals were killed 
for culture and histopathologic examination of  joints and other 
organs  (see below). 
In group I mice signs of an equilibrium  disorder began 
on day 19 or later for four of five B-inoculated mice and day 
29 for one of four A-inoculated mice (Fig. 2). The manifesta- 
tions were head tilt, walking in circles in one direction, and 
spinning  in the air when lifted off the ground by the tail. 
When deprived of proprioceptive  input from the ground, 
the affected animals attempted to achieve a supported posi- 
tion. This disorder, like those of  eyes and joints, resolved after 
a few days. There was no evidence of hemiparesis, abnormal 
posture,  or involvement  of cranial nerves other than VIII 
during the period of examination. 
Assessment of  Functional Impairment.  Traversing  an elevated 
narrow beam assesses both locomotor performance and ves- 
tibular system integrity of rodents (41). After mice in group 
I had first been trained for walking the beam, they were in- 
oculated with PBS, serotype A, or serotype B as described 
above. Traversing times and footslips were measured daily for 
days 1-15 and 29-31 and every other day for days 16-28. Fig. 
4 shows in radar graphs the results with the A- and B-inocu- 
lated and control mice that were followed for 31 d. The results 
obtained with mice examined daily for 4 or 11 d after inocu- 
lation were the same for these time periods as those obtained 
with mice examined for 31 d  (data not shown). 
The mean number of foot slips for control mice in 312 
trials was 0.2 per crossing. Only mice infected with serotype 
B had functional impairment by the criterion of number of 
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footslips (Fig. 4). The impairment in B-inoculated mice was 
greatest during days 10-14 and 20-27, the respective periods 
of  joint and vestibular disorders. On day 11, when B-inoculated 
but not A-inoculated mice had  joint disease, the mean number 
(95% CI) of foot slips was 0.1 (0-0.3) for A-inoculated mice 
and 16 (6-26)  for B-inoculated  mice. 
Crossing times were more variable within groups (Fig. 4). 
The mean (SD) crossing time for uninfected mice in 312 trials 
was 16 (6) s. Crossing times in A-inoculated mice were lon- 
gest between days 8 and 19, when minimal joint swelling 
occurred, and between days 29 and 31 when one mouse had 
vestibular disorder. Some A-inoculated mice had crossing times 
Table  1.  Inflammation  of the Joints of scid Mice Infected with B.  turicatae Serotypes A  or B 
Serotype  A 
None*  Mild  Moderate  Severe  None 
Scrotype  B 
Mild  Moderate  Severe 
Knees  4  0  0  0  0  0  3  1 
Tibiotarsal  0  2  2  0  0  0  1  3 
Metatarsophalangeal  0  4  0  0  1  2  1  0 
Metacarpophalangeal  1  3  0  0  0  2  1  1 
Elbow  3  1  0  0  0  4  0  0 
Total  8  10  2  0  1  8  6  5 
* See Materials  and Methods for criteria. 
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were longer in B-inoculated mice;  only mice in this group 
had crossing times of 75  s or more.  On day 12 the mean 
crossing times (95% CI) for A- and B-inoculated mice were 
17 (6-28) and 49 (32-66) s, respectively. As with foot slips, 
the greatest impairment  in beam walking for B-inoculated 
mice corresponded to the periods of joint and later of ves- 
tibular  disorders. 
Histopathology.  Blinded examinations were made on tissues 
of the eight group II mice kiUed on day 15 after inoculation 
and two uninfected scid mice of the same age. Most B-inocu- 
lated mice had reddened,  swollen joints at this time, while 
A-inoculated mice had joints that were somewhat larger than 
controls but smaller than those of B-inoculated mice. Table 
1 summarizes  histologic findings  in the joints  of serotype 
A- and B-inoculated  mice;  control mice did not  have any 
detectable inflammation  of the joints or tendon  sheaths.  8 
of 20 examined joints of A-inoculated mice were normal com- 
pared with  1 of 20 in serotype B-inoculated mice (p <0.01 
by Fisher  exact test).  11 of 20 joints of B-inoculated mice 
and 2 of 20 joints of A-inoculated mice had moderate to se- 
vere inflammation  (p <0.01).  Only B-inoculated mice had 
severe arthritis.  An example of severe  arthritis  in a mouse 
inoculated with  serotype B is shown in Fig.  5.  There is a 
mixed inflammation of the synovial lining of the joints and 
tendon sheaths with mononuclear and polymorphonuclear 
cells, and the synovial lining is thickened with several layers 
of ceUs. 
Heart inflammation graded mild or moderate was observed 
in all infected mice but not in the controls.  There was not 
a significant difference between serotypes A and B with re- 
spect to the degree of inflammation.  The myocarditis was 
characterized  by a  predominantly  mononuclear  leukocytic 
infiltrate between myocardial fibers.  The inflammation  was 
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Figure 5.  Histopathology  ofjoints ofsc/dmice 
examined 15 d after  inoculation ofR tur/catae  sero- 
type B. Paraffin sections  were stained with heraa- 
toxylin-eosin. (A) Arrowhead points to general- 
ized thickening of the synovial  lining of a tarsal 
joint.  Leukocyte  and fibrinous e~udate are also 
present in the joint space  (x44). (B) Arrowheads 
point to thickened synovial membrane (bottom 
arrow) and exudation of  mixed leukocytes  into the 
knee joint space (top arrow) (￿ greatest in the atria and around the base of the great vessels. 
There was also an epicarditis and pericarditis that was most 
marked over the atria and base of the heart. 
Two serotype B-inoculated scid mice were killed when they 
had vestibular disorder; a mouse similarly  infected  but without 
this disorder was killed at the same time. When their brain 
and middle and inner ears were examined microscopically, 
no evidence of inflammation of these tissues was found. In 
neither these mice nor the group II mice described above  were 
there abnormalities of the liver, bladder, pancreas, or spleen. 
The  testes  of both  A-  and  B-inoculated  mice contained 
numerous spirochetes in fluid obtained by puncture but no 
leukocytic infiltrate on histologic examination. These histo- 
logic studies demonstrated that serotype A and B differed 
only in the degree of inflammation they caused in the  joints. 
Serotype A  Is Neurotrapic during Early Infection.  The finding 
in the scid mouse examined after 100 d of infection suggested 
that serotype A was more likely than serotype B to infect 
the brain. To further study this phenomenon 103 cells of the 
"bl00" isolate (Fig. 1), in which only serotype A was detect- 
able, or the "pl00" isolate which was predominantly sero- 
type B, were inoculated into five scid mice each on day 0. 
On day 8 the plasma and brain were cultured, and the first- 
passage culture harvests were subjected to PAGE for identi- 
fication of the serotype. For this and subsequent experiments 
the blood was obtained first; only after exsanguination and 
total body perfusion with PBS was the brain taken (33). The 
results of this experiment, the first in this series, are given 
in Table 2. Plasma and brain cultures from the five mice in 
each group were positive. Mice inoculated with the bl00 iso- 
late had serotype A in both the plasma and brain.  In con- 
trast, the mice inoculated with the pl00 isolate had both sero- 
type A and B in the plasma but only serotype A in the brain, 
even though serotype A represented no more than 10% of 
the inoculum in these mice (Fig. 1). In this and subsequent 
experiments there were, as estimated by number of days in 
culture to reach 106 ceUs/ml, 10-100-fold fewer borrelias per 
volume of brain tissue than in the same volume of plasma. 
In experiment 2 of this part of the study cultures of the 
brain and plasma were taken from scid mice 5-29 (group I) 
inoculated with either serotype A or B and killed on days 
4, 11, and 31. These times represented early infection (day 
4), arthritis in B- but not A-inoculated mice (day 11), and 
vestibular disorder in A- and B-inoculated  mice (day 31). Blood 
cultures were also obtained  from the mice on days 18 and 
22. Whereas mice inoculated with serotype A had positive 
plasma and brain cultures on days 4 and 11, B-inoculated mice 
had positive plasma cultures but negative brain cultures on 
these days (Table 2). The borrelias recovered in these cultures 
were the same serotypes used to inoculate  the animals. 
On day 31 all nine mice had positive brain as well as plasma 
cultures (Table 2). Whereas in A-inoculated mice only sero- 
type A was detectable in blood and brain, B-inoculated mice 
had, besides serotype 13, a new serotype in blood and brain 
on day 31. This new serotype, which was designated C, had 
a Vmp of 21 K (Fig. 6). The representation  of serotype C 
was higher in brain cultures than in plasma cukures simul- 
taneously obtained. Serotype C was detectable in the plasma 
cultures  of only one of the five mice on day 22 and none 
of the mice on day 18 (data not shown). An additional 4 d 
of  incubation was required before  brain cultures of  B-inocuhted 
mice, in comparison to A-inoculated mice, reached a cell den- 
sity of 106/ml. This indicates that  there were '~100-fold 
fewer borrdias in the brains of  B-inoculated than A-inoculated 
mice examined on day 31. 
Inasmuch as a new serotype, C, appeared in the blood and 
brains of mice inoculated with a clonal population of sero- 
type ]3, it was possible that some scid mice were producing 
Table  2.  Cultures  of Mice Infected with B.  turicatae Serotypes A  and B 
Serotype  Day 
Exp.  inoculated  examined 
Serotypes in 
Culture results*  culture* 
Plasma  Brain  Plasma  Brain 
1  A + B s  8  5/5  5/5  A,  B  A 
A  8  5/5  5/5  A  A 
2  A  4  4/4  4/4 II  A  A 
B  4  4/4  0/4 II  B  - 
A  11  4/4  4/411  A  A 
B  11  4/4  0/4 II  B  - 
A  31  4/4  4/4  A  A 
B  31  5/5  5/5  B,  C  B,  C 
3  A + B s  4  4/4  4/4  A,  B  A 
* Number of mice with positive cultures/number of mice cultured. 
* As determined by electrophoretic  migrations of Vmp proteins  (see text). 
S A/B,  1:10 in experiment  1 (Fig.  1) and A/B,  1:1 in experiment  3. 
lip  =  0.01 by Fisher exact test. 
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stained proteins  of isolates from 
phsma (p) or brain (b) of a mouse 
sampled on days 18, 22, and 31 
after  inocuhtion with  a  clonal 
population of serotype  B  of R 
aa/catae. For comparison lysates  of 
serotype B and A cells are in the 
rightmost two lanes. The samples 
fixnn  the plasma  were purposefully 
overloaded with  respect  to  the 
brain isolate. The arrow indicates 
a protein of 21 K in the lane of 
p31.  This protein is  in greater 
amounts in the b31 population. 
The a~'lami&  concentration  was 
12.5%. The migrations of  molec- 
ular weight standards  (x 1,000) are 
shown on the left. 
Figure  7.  Coomassie  blue- 
stained protdns of isohtes  from 
plasma (p) or brain (b) of two sc/d 
mice  (nos.  1 and 2)  inoculated 
with a 1:1 mixture of serotypos 
A and B of R  tur/cata~ For com- 
parison lysates of serotype A and 
B ceils are in the two leftmost 
hnes. The samples from the brain 
were  purposefully  overloaded  with 
respect to the plasma isohtes. The 
arrows  indicate  the presence of 
VmpB of 20 K in the plasma iso- 
lates. The acrylamide concentra- 
tion was 12.5%. The migrations 
of  molecuhr  weight  standards 
(x 1,000) are shown on the left. 
specific antibodies (42). To assess this possibility we exam- 
ined sera from scid mice 4, 11, and 31 d after inoculation of 
serotype A or B cells by indirect immunofluorescence. None 
of the sera examined reacted with serotype A or B cells. In 
contrast,  the sera from immunocompetent BALB/c mice in- 
oculated with clonal populations  of serotype A  or B cells 
produced serotype-spedfic antibodies under the same condi- 
tions and in the same assay (data not shown).  This was an 
indication that there was not antibody sdection by the scid 
mice against  the serotypes originally inoculated. 
One explanation for the presence of serotype B in the brain 
by day 31 was that entry into the brain was facilitated by 
prior invasion of a neurotropic serotype. We evaluated this 
possibility by infecting mice with a mixture of donal popu- 
lations of serotype B and serotype A. For this experiment, 
number 3 in the series, four scid mice were infected with 
5  x  103 each of serotype A and B cells on day 0.  Plasma 
and brain were obtained and cultured on day 4. The results 
of cultures of two of the mice (nos. 1 and 2) are shown in 
Fig. 7; results with the other two mice were the same (Table 
2). The lanes with lysates of brain cultures from mice nos. 
I  and 2 were purposefully overloaded. Serotypes A and B 
were both present in the plasma, but only serotype A was 
detectable in the brain cultures. These findings confirmed that 
entry into the brain in early infection with R  turicatae was 
characteristic of serotype A but not B. Simultaneous inocu- 
lation with a neurotropic serotype did not facilitate early in- 
fection of the brain by serotype B. 
To evaluate the ability of serotype B to proliferate and sur- 
vive in the brain, 103 borrelias of serotype B were inoculated 
intracerebral!y into three 4-wk-old scid mice. 8 d later plasma 
and perfused brain were obtained from the animals and cul- 
tured. Serotype B was found in both the plasma and brain 
of all three animals. This experiment showed that serotype 
B has the ability at least to survive in the brain,  and, thus, 
its absence from the brains of mice infected peripherally is 
more likely the consequence of lower invasiveness. In this 
respect the culture findings were consistent with the results 
of the in vitro invasion assay. 
Cultures of  Joints and Eyes.  Borrelias were recovered from 
all perfused tibiotarsal joints taken on day 14 from four A- 
and four B-inoculated mice. The serotype in the culture was 
the same as that used to inoculate the animals. These results 
suggest that serotypes A and B have equal ability to invade 
the  joints. Eye cultures were positive from all A- and B-inocu- 
lated mice cultured on days 11 and 31. Inasmuch as the B- 
inoculated mice had negative brain cultures on day 11, the 
access route to the eye was likely the systemic circulation and 
not the subarachnoid  space. 
Discussion 
Recent progress in our collective understanding of patho- 
genesis of infectious diseases has primarily been at the level 
of  the microorganism or the interface between pathogen and 
eukaryotic  cell. At one time animal infections were the prin- 
cipal experimental tool of investigators, but now generally 
less is known about the disease itself than about the molec- 
ular and cell biology of the etiologic agent. An impediment 
to reaching a fuller understanding of disease is the very com- 
plexity of  the pathogenic process in an infected animal. Inva- 
sire or otherwise virulent microorganisms  usually employ 
more than one strategy to enter and proliferate in the host 
and subsequently disseminate to new hosts. Moreover, the 
host responds to the pathogen in a variety of ways, specific 
as well as nonspecific. One way to sort out what is essential 
for virulence is to create mutants that are defective in one 
suspected virulence trait at a time and observe for the amount 
of disease in inoculated animals. This approach has led to the 
identification or confirmation of  a number of  virulence factors 
and the genes that encode them. An approach complemen- 
tary to directed mutagenesis is the study of spontaneously 
occurring pathogen polymorphisms for their effects in an- 
imal hosts. Although this type of investigation often begins 
more empiricafiy than directed mutagenesis,  it has the ad- 
vantage that manifestations  may be qualitatively as weU as 
quantitatively  different between variants. When otherwise 
homogeneous populations have  two or more alleles  for a locus, 
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circumstances proliferation  of calls expressing the alternate 
allele is favored. The polymorphisms may only reflect a shift 
in the population from invaders to colonizers, but there may 
also be more profound differences in disease expression. The 
present study did not start with this second strategy in mind 
but ended showing its benefits. 
The major findings were these: (a) donal populations  of 
two serotypes, A and ]3, of R  turicatae were similar in their 
ability to infect the blood of mice, to cause myocarditis and 
peripheral vestibular disorder, and to invade the eyes  and testes; 
(b) serotype B but not A caused reddening and significant 
swelling of the joints, marked functional impairment on a 
walking bar, and severe arthritis by histologic examination; 
(c) serotype A but not B invaded the brain early in infection; 
and (a') serotype A penetrated monolayers of human umbil- 
ical vein endothelial cells more readily than did serotype B. 
Invasion of the mouse brain by/~ hermsii and R  turicatae 
was expected. Other investigators had reported infection of 
the brains of mice by relapsing fever borrelias (18, 43), and 
we recently established that R  hermsii invades the brain and 
cerebrospinal fluid of mice (33). Past investigators had sug- 
gested that certain strains of relapsing fever Borrelia species 
were neurotropic and that others were not (44). These ob- 
servations were made on either different strains or uncloned 
populations of borrdias. In the present study we found that 
serotype A was neurotropic and serotype B was not during 
early infection. In three experiments, including two in which 
mixed infections were studied, both serotype A and B prolifer- 
ated in the blood, heart, joints, and eye but only serotype 
A was found in the brain for at least 11 d of infection. Sero- 
type A also infected the brain ofimmunocompetent  BALB/c 
mice for at least 14 d (Kazragis, R., and A. G. Barbour, un- 
published findings). These results were not attributable  to 
a failure of serotype B to grow in the brain. Rather it appears 
to be the consequence of decreased entry of serotype B in 
comparison to A into the central nervous system. An in vitro 
correlate of this behavior was comparatively impaired penetra- 
tion of an endothelial cell monolayer by serotype B. By day 
31 serotype B was present in the brain in small numbers, but 
this was only after another serotype, C, had appeared. When 
simultaneous cultures of plasma and brain were compared, 
there was greater representation of C in the brain, a finding 
that suggests that serotype C is also neurotropic.  Although 
R  turicatae invaded the brain early and persisted there for up 
to 100 d, there was no apparent inflammation of the brain 
by routine histopathologic  examination. 
Neurologic manifestations or complications are common 
in both relapsing fever and Lyme borreliosis (1, 12), but there 
have been, to our knowledge, no reports of neurologic dis- 
orders in experimental models of  either relapsing fever  or Lyme 
borrdiosis. Evidence that the vestibular disorder resulted from 
a VIII cranial neuritis  rather than from a central lesion or 
otitis were the following:  the involvement appeared to be 
limited to the vestibular function and was unilateral,  there 
was no evidence of involvement  of either the inner ear or 
the brain on pathologic  examination,  and it was limited in 
duration (31). 
A specific antibody response to either serotype was not 
detected in the scid mice. Although a cell-mediated spedfic 
immune response can not be excluded, previous studies had 
shown that elimination of R turicatae or R hermsii from the 
blood is a T cell-independent immune response in mice (ref- 
erence 45; A.G. Barbour, unpublished findings). It is likely 
that the resolution of the mucopurulent eye discharge, the 
arthritis,  and the vestibular disorder is attributable  to non- 
specific host responses. The scid mouse, as well as other labo- 
ratory animals with defined immune delidencies, allows the 
aforementioned  complexity of the animal-pathogen interac- 
tion to be reduced for experimental  study. 
An unexpected finding of the study was the marked ar- 
thrifts in all mice infected with serotype B; A-inoculated mice 
had only mild to moderate inflammation of the joints that 
produced only minimal functional impairment on the walking 
bar. Arthritis had not been noted as a manifestation or com- 
plication of relapsing fever in humans or in experimental in- 
fections in animals. In our previous studies of R  hermsii we 
had never observed arthritis in mice, even in scid mice that 
were spirochetemic for weeks (unpublished  findings).  The 
character and distribution of the arthritis and synovitis were 
very similar to what has been observed in immunodeficient 
mice infected with R burgdo~feri (11). The severity of arthritis 
with R  turicatae appears to be the function of the Vmp. Al- 
though there is evidence that OspB of R  burgdorferi confers 
some degree of infectivity to that species (46), there has not 
been attribution of the severity of arthritis  to a particular 
component in BL burgdorferi. An infectious but nonarthrito- 
genic strain of R  burgdorferi has been characterized, but an 
association with a specific protein was not established (47). 
The only discernible  difference  in components between sero- 
types A and B was their Vmp proteins. Although the popu- 
lation used to infect the first scid mice was not strictly clonal, 
the similarities between the serotype A and B populations 
with respect  to protein and restriction enzyme fragment 
profiles indicate that the two populations were isogenic. The 
finding of four other size polymorphisms of the Vmp pro- 
tein suggest that there is a repertoire of vmp genes and that 
variation of this protein in R  turicatae has a similar basis to 
that in the closely related species B~ hermsii, which escapes 
immune clearance  by multiphasic antigenic variation (35, 48). 
In R  hermsii, the Vmp proteins serve as the target for neu- 
tralizing antibody (22, 24), but another function for the pro- 
tein has not been identified. The present study indicates that 
Vmp variability not only confers an ability to escape from 
the immune system  but also a mechanism whereby the progeny 
of the founder population could sort out into different niches 
in the host. The differences  in pathogen localization and organ 
involvement by R turicatae in scid mice were evidence of this. 
Serotype A invaded the central nervous system earlier and 
penetrated endothelial cell monolayers better than did sero- 
type B. Presumably this invasive capability demonstrated in 
vitro and in vivo was a function of VmpA. On the other 
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mation  of the joints,  notwithstanding  the apparent  equal 
ability of both serotypes to invade the joints. Vmp structure 
may be the proximate determinant  of disease expression in 
this animal  model. 
A  similar phenomenon was found during  studies of the 
reovirus,  another neurotropic pathogen. Field et al. (49) found 
that the viral hemagglutinin that determines serotype-speci- 
ficity was also responsible for neurotropic potential and the 
type of nervous system disease that occurred. When a type 
1 protein is expressed on the surface, it results in ependymal 
destruction and subsequent hydrocephalus. In contrast,  if a 
type 3 protein is expressed, a necrotizing encephalitis with 
neuronal  destruction  but  not  ependymal  damage  occurs. 
Among bacteria the protein II family of proteins of Neisseria 
gonorrhoeae is the example that most dosely resembles what 
we observed with/~ turicatae (50). Protein II antigenic varia- 
tion occurs during infection, and organisms expressing dif- 
ferent protein II variants differ in their adherence to host cells, 
including  phagocytic and epithelial  ceUs. 
We have up to this point discussed the results primarily 
within the context of borrelias and other infectious agents. 
Reviewing the disorders of the R  turicatae infected scid mice, 
we were struck by the similarity of their clinical presentation 
to what has been observed in humans with systemic Lyme 
borreliosis (1). Doubtless there are reasons to defer proposing 
full equivalence between animal model and human disorder: 
the organisms are different species of Borrelia, and the mice 
were immunodeficient. Nevertheless, the R  mr/came-infected 
scid mice had more features of systemic Lyme borreliosis than 
have been observed to date in any other laboratory animals 
infected  with  /g  burgdo~feri, even  those  equivalently  im- 
munodeficient (51). In common with animals infected with 
R  burgdolferi, the R  turicatae-infected  animals  had myocar- 
ditis, and arthritis. Another similarity with Lyme borreliosis 
is the different stages and remitting  course in the mice in- 
fected with  R  turicatae (52).  What  the/g  turicatae modal 
uniquely offers is a neurologic disorder, consistent and per- 
sistent infection of the brain,  and involvement  of the eye. 
Of particular relevance for understanding  the pathogenesis 
of the arthritis  of Lyme borreliosis was the association of 
marked  arthritis  with  a  particular  surface  protein  of the 
borrelia. One of the distinctions between Lyme borreliosis 
in North America and Europe is the infrequency of chronic 
arthritis in northern and eastern Europe (1, 53). This differ- 
ence in disease expression may be the consequence of differ- 
ences between the local etiologic agents (54). The invasion 
of and persistence in the brain by R  turicatae may also have 
relevance for studies of other chronic spirochetal diseases of 
the nervous system, syphilis, and the phenomenon of neu- 
rotropism  in general. 
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